Chemo-Free hope: new drug cocktail targets aggressive lymphoma
Disease control
Not yet recruiting
This Phase II trial is testing a combination of three drugs—glofitamab, polatuzumab vedotin, and zuberitamab—in 40 people newly diagnosed with diffuse large B-cell lymphoma. The goal is to see if this chemo-free approach can achieve complete remission early in treatment. Particip…
Phase: PHASE2 • Sponsor: Li Zhiming • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC